Effects of testosterone enanthate on the structure of the male reproductive tract of the rat.
The histology and fine structure of the testis, epididymis and sex accessory glands were studied in young adult male rats administered testosterone enanthate, 120 microgram/100 g body weight, three times weekly for 4, 8, or 12 weeks. The weights of the testis and epididymis decreased, and animals treated for 11 weeks were infertile. Alterations were found in the seminiferous tubules of all rats treated for 8 or 12 weeks, including the presence of many degenerating germ cells and a large decrease or absence of late spermatids. Study of different stages of the cycle of the seminiferous epithelium showed that the greatest number of degenerating germ cells, step 7 spermatids and pachytene primary spermatocytes, occurred at stages VII-VIII of the cycle. Some normal appearing spermatogonia, primary spermatocytes and early spermatids remained in most seminiferous tubules. Sertoli cells contained many lipid droplets and lysosome-like bodies, and degenerating cells were surrounded by Sertoli cell cytoplasm. The Leydig cells of treated animals were greatly reduced in size. Sperm progressively disappeared from the lumen of the middle segment and proximal part of the terminal segment of the epididymis after treatment for 8 or 12 weeks. Changes in the middle segment also included the appearance of intraepithelial cavities containing debris, and the presence within the epithelium of phagocytic cells that resembled leukocytes. The lumen of the proximal part of the terminal segment was often collapsed, while in the distal part of the terminal segment, the lumen was filled with cellular debris and degenerating sperm. Organelles of the principal cells of the epididymal epithelium appeared to be qualitatively unaltered. The weight of the sex accessory glands remained close to normal, and the presence of normal ultrastructural features suggested that production of secretions continued.
D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D004822:Epididymis / Q000187:drug effects* / Q000648:ultrastructure; D006537:Heptanoates; D007985:Leydig Cells / Q000187:drug effects; D008297:Male; D011467:Prostate / Q000187:drug effects* / Q000648:ultrastructure; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects* / Q000648:ultrastructure; D012670:Seminiferous Epithelium / Q000187:drug effects / Q000648:ultrastructure; D013087:Spermatids / Q000187:drug effects; D013090:Spermatocytes / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects; D013737:Testis / Q000187:drug effects* / Q000648:ultrastructure; D013739:Testosterone / Q000494:pharmacology*
D006537:Heptanoates; D013739:Testosterone